Click to view full size
Aventa has denied that it has received preferential treatment in terms of payments by NIPDEC.
In an internal memo dated February 27, the company addressed staff following a Public Administration and Appropriations Committee (PAAC) meeting on February 23, when Nipdec general manager Vyas Ramphalie told the committee that between 2023 and 2025, he had been instructed by former Health Minister to prioritise payments to Aventa, the pharmaceutical distribution and manufacturing arm of the Agostini Group, over all other companies.
Deyalsingh has since denied the allegation.
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
Related stories
See articles related to "Aventa tells staff it got no special treatment on payments"